Synthesis and structure-activity relationships of 2-(substituted phenyl)-3-[3-(N,N-dimethylamino)propyl]-1,3-thiazolidin-4-ones acting as H1-histamine antagonists. 1999

M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli Federico II, Naples, Italy. diurno@unina.it

2-(Substituted-phenyl)-3-[3-(N,N-dimethylamino)propyl]-1,3-thiazolidi n-4- ones (1-15) showed dependence of the potency of the H1-histamine antagonism on the m- and p-substituents suggesting that the aromatic moiety binds the receptor by a strong pi-interaction. Electron-withdrawing substituents decrease the potency while the electron-donating alkyl substituents, enhancing the aryl HOMO energy, increase the antihistamine activity. The m-substituents with the capability to form hydrogen bonds, seems to share an extra-interaction with hydrogen accepting or donating groups of the histamine receptor and exhibits very high potency.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole

Related Publications

M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
January 2011, Acta poloniae pharmaceutica,
M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
September 2009, Indian journal of pharmaceutical sciences,
M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
February 2013, Journal of enzyme inhibition and medicinal chemistry,
M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
September 2014, Journal of biochemical and molecular toxicology,
M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
January 2009, Acta poloniae pharmaceutica,
M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
April 2005, Acta crystallographica. Section C, Crystal structure communications,
M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
January 2014, Drug research,
M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
April 2016, Bioorganic & medicinal chemistry letters,
M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
November 2002, Journal of medicinal chemistry,
M V Diurno, and O Mazzoni, and G Correale, and I Gomez Monterrey, and A Calignano, and G La Rana, and A Bolognese
January 2009, European journal of medicinal chemistry,
Copied contents to your clipboard!